Switch theme
Sign up to access all valuation multiples
PZ Cussons PLC is a household and personal-care company. Its main business categories are personal care and beauty, home care, food and nutrition, and electricals. The principal activities of the Group are the manufacture and distribution of soaps, detergents, toiletries, beauty products, pharmaceuticals, electrical goods, edible oils, fats and spreads, and nutritional products. The geographical segments of the company are Europe and the Americas, Asia Pacific, Africa, and the Central regions. The company derives its maximum revenue from Europe and the Americas.
1884
2.6K+
LTM Revenue $692M
LTM EBITDA $97.1M
$578M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
PZ Cussons has a last 12-month revenue (LTM) of $692M and a last 12-month EBITDA of $97.1M.
In the most recent fiscal year, PZ Cussons achieved revenue of $721M and an EBITDA of -$75.5M.
PZ Cussons expects next 12-month revenue of XXX and NTM EBITDA of XXX
See PZ Cussons valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $692M | XXX | $721M | XXX | XXX | XXX |
| Gross Profit | $282M | XXX | $179M | XXX | XXX | XXX |
| Gross Margin | 41% | XXX | 25% | XXX | XXX | XXX |
| EBITDA | $97.1M | XXX | -$75.5M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | -10% | XXX | XXX | XXX |
| EBIT | $73.3M | XXX | -$60.2M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | -8% | XXX | XXX | XXX |
| Net Profit | $41.4M | XXX | -$77.8M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | -11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $157M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, PZ Cussons's stock price is GBP 1 (or $1).
PZ Cussons has current market cap of GBP 307M (or $419M), and EV of GBP 423M (or $578M).
See PZ Cussons trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $578M | $419M | XXX | XXX | XXX | XXX | $0.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, PZ Cussons has market cap of $419M and EV of $578M.
PZ Cussons's trades at 0.8x EV/Revenue multiple, and 22.9x EV/EBITDA.
Equity research analysts estimate PZ Cussons's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
PZ Cussons has a P/E ratio of 10.1x.
See valuation multiples for PZ Cussons and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $419M | XXX | $419M | XXX | XXX | XXX |
| EV (current) | $578M | XXX | $578M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 6.0x | XXX | 22.9x | XXX | XXX | XXX |
| EV/EBIT | 7.9x | XXX | 32.4x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 10.1x | XXX | -51.4x | XXX | XXX | XXX |
| EV/FCF | 18.0x | XXX | 27.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPZ Cussons's last 12 month revenue growth is 3%
PZ Cussons's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
PZ Cussons's rule of 40 is 5% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
PZ Cussons's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for PZ Cussons and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | 227% | XXX | XXX | XXX |
| Rule of 40 | 5% | XXX | 7% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PZ Cussons acquired XXX companies to date.
Last acquisition by PZ Cussons was XXXXXXXX, XXXXX XXXXX XXXXXX . PZ Cussons acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was PZ Cussons founded? | PZ Cussons was founded in 1884. |
| Where is PZ Cussons headquartered? | PZ Cussons is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does PZ Cussons have? | As of today, PZ Cussons has 2.6K+ employees. |
| Who is the CEO of PZ Cussons? | PZ Cussons's CEO is Mr. Jonathan Myers. |
| Is PZ Cussons publicy listed? | Yes, PZ Cussons is a public company listed on LON. |
| What is the stock symbol of PZ Cussons? | PZ Cussons trades under PZC ticker. |
| When did PZ Cussons go public? | PZ Cussons went public in 1953. |
| Who are competitors of PZ Cussons? | Similar companies to PZ Cussons include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of PZ Cussons? | PZ Cussons's current market cap is $419M |
| What is the current revenue of PZ Cussons? | PZ Cussons's last 12 months revenue is $692M. |
| What is the current revenue growth of PZ Cussons? | PZ Cussons revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of PZ Cussons? | Current revenue multiple of PZ Cussons is 0.8x. |
| Is PZ Cussons profitable? | Yes, PZ Cussons is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of PZ Cussons? | PZ Cussons's last 12 months EBITDA is $97.1M. |
| What is PZ Cussons's EBITDA margin? | PZ Cussons's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of PZ Cussons? | Current EBITDA multiple of PZ Cussons is 6.0x. |
| What is the current FCF of PZ Cussons? | PZ Cussons's last 12 months FCF is $32.0M. |
| What is PZ Cussons's FCF margin? | PZ Cussons's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of PZ Cussons? | Current FCF multiple of PZ Cussons is 18.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
